Hap Trading, LLC Galapagos Nv Put Options Transaction History

Hap Trading, LLC

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 12, 2022	SELL	$51.32 - $68.5 $1.37 Million - $1.82 Million	-26,600 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$47.03 - $57.12 $1.19 Million - $1.45 Million	-25,400 Reduced 48.85%	26,600 $325,000
Q3 2021 Nov 10, 2021	BUY	$52.17 - $70.2 $2.71 Million - $3.65 Million	52,000 New	52,000 $652,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.